Fig. 8From: Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experimentsExpression and the prognosis value of PKP2 in ovarian cancer. A Immunohistochemical staining of PKP2 in malignant tissues (a), borderline tissues (b), benign tissues (c), and normal tissues (d). B Relationship between PKP2 expression, FIGO stage, lymph node metastasis and prognosis of patients with ovarian cancerBack to article page